+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

IPX203 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

IPX203 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
From
From
From
From
From
From
From
Global Parkinson's Disease Drugs Market 2018-2024 - Product Thumbnail Image

Global Parkinson's Disease Drugs Market 2018-2024

  • Report
  • March 2019
  • 110 Pages
  • Global
From
ND0612 - Product Thumbnail Image

ND0612

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Neupro - Product Thumbnail Image

Neupro

  • Report
  • June 2018
  • 14 Pages
  • Global
From
Disease Analysis: Parkinson's Disease - Product Thumbnail Image

Disease Analysis: Parkinson's Disease

  • Report
  • March 2021
  • 75 Pages
  • Global
Azilect - Product Thumbnail Image

Azilect

  • Report
  • June 2018
  • 16 Pages
  • Global
From
Duopa - Product Thumbnail Image

Duopa

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Ongentys - Product Thumbnail Image

Ongentys

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Inbrija - Product Thumbnail Image

Inbrija

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more